Advertisement

Topics

Metastatic granulosa cell tumours and PARP inhibitors

07:31 EDT 12 Jul 2018 | ecancermedicalscience

Prof Ray-Coquard speaks with ecancer at BCGS about the importance of initial diagnosis and molecular analysis in the management of granulosa cell type ovarian cancers. She also discusses clinical trials in this indication, including an upcoming...

Original Article: Metastatic granulosa cell tumours and PARP inhibitors

NEXT ARTICLE

More From BioPortfolio on "Metastatic granulosa cell tumours and PARP inhibitors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...